Gene · 8081
Papers1,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The investigation of the dynamics of changes in neutralizing antibody titers against type 5 adenovirus in the context of vaccination against a new coronavirus infection. | Virology | 2024 | 38489915 | PubTator, text mining | PubMed |
| Organismal Function Enhancement through Biomaterial Intervention. | Nanomaterials (Basel) | 2024 | 38392750 | PubTator, text mining | PubMed |
| Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency. | Sci Transl Med | 2024 | 38324638 | PubTator, text mining | PubMed |
| Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice. | Mol Ther | 2024 | 38311852 | PubTator, text mining | PubMed |
| Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model. | Vaccine | 2024 | 38296705 | PubTator, text mining | PubMed |
| Efficient and sustained FOXP3 locus editing in hematopoietic stem cells as a therapeutic approach for IPEX syndrome. | Mol Ther Methods Clin Dev | 2024 | 38282895 | PubTator, text mining | PubMed |
| Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models. | Int J Mol Sci | 2024 | 38279262 | PubTator, text mining | PubMed |
| Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection. | Nat Commun | 2024 | 38278794 | PubTator, text mining | PubMed |
| Increased cysteinyl-tRNA synthetase drives neuroinflammation in Alzheimer's disease. | Transl Neurodegener | 2024 | 38191451 | PubTator, text mining | PubMed |
| VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. | J Immunother Cancer | 2024 | 38184304 | PubTator, text mining | PubMed |
| Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer. | J Transl Med | 2024 | 38167076 | PubTator, text mining | PubMed |
| Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy. | J Cancer | 2024 | 38164273 | PubTator, text mining | PubMed |
| A Novel Role for the Adenovirus L4 Region 22K and 33K Proteins in Adeno-Associated Virus Production. | Hum Gene Ther | 2024 | 38062776 | PubTator, text mining | PubMed |
| Development of Adenovirus-Based Covid-19 Vaccine Candidate in Indonesia. | Mol Biotechnol | 2024 | 37076664 | PubTator, text mining | PubMed |
The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18-59 Years and over 60 Years Based on Two Randomized Controlled Trials in China. | Vaccines (Basel) | 2023 | 38140219 | PubTator, text mining | PubMed |
| USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity. | Mol Cancer | 2023 | 38093367 | PubTator, text mining | PubMed |
| Evaluation of Seroconversion Rate Following SARS COV 2 Vaccination in Health Care Workers at Shahid Beheshti University of Medical Sciences. | Avicenna J Med Biotechnol | 2023 | 38078340 | PubTator, text mining | PubMed |
| AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes. | Sci Rep | 2023 | 38066084 | PubTator, text mining | PubMed |
| Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18-60 Years: a Single-Center, Open-Label Trial. | Infect Dis Ther | 2023 | 38038866 | PubTator, text mining | PubMed |
| Progress in oncolytic viruses modified with nanomaterials for intravenous application. | Cancer Biol Med | 2023 | 38009779 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8081/papers?page=2